lactic acid and oxidopamine

lactic acid has been researched along with oxidopamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fronek, K1
Petty, F; Sherman, AD1
Dahlström, A; McRae, A1
Chen, Y; Hong, X; Liu, Z; Song, L; Wu, N; Yang, X; Yuan, W1
Che, JY; Gan, J; Liu, ZG; Song, L; Wang, WW; Xie, CL; Yuan, ML; Yuan, WE; Zhang, SF1
Arun, J; Bhatnagar, P; Chaturvedi, RK; Chaudhari, BP; Chauhan, LK; Gupta, KC; Khanna, VK; Kumar, P; Pahuja, R; Patel, DK; Saxena, PN; Seth, K; Shukla, A; Shukla, R; Shukla, RK; Singh, SP1
Alves-Dos-Santos, L; Barna, BF; Britto, LR; Chiavegatto, S; Moreira, TS; Takakura, AC; Tuppy, M1
Filiz, Z; Korkmaz, OT; Kuş, G; Şener, E; Tunçel, N; Ulupinar, E; Yelkenli, İH1

Other Studies

8 other study(ies) available for lactic acid and oxidopamine

ArticleYear
Trophic effect of the sympathetic nervous system on vascular smooth muscle.
    Annals of biomedical engineering, 1983, Volume: 11, Issue:6

    Topics: Acetylglucosaminidase; Animals; Aorta; Arteriosclerosis; Citric Acid Cycle; Cocaine; Collagen; Columbidae; Glucuronidase; Hydroxydopamines; Iliac Artery; Lactates; Lactic Acid; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Procollagen-Proline Dioxygenase; Rabbits; Sympathectomy, Chemical; Sympathetic Nervous System

1983
A pharmacologically pertinent animal model of mania.
    Journal of affective disorders, 1981, Volume: 3, Issue:4

    Topics: Affective Disorders, Psychotic; Animals; Bipolar Disorder; Disease Models, Animal; Electroshock; Humans; Hydroxydopamines; Imipramine; Injections, Intraventricular; Lactates; Lactic Acid; Lithium; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains

1981
Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism.
    Neurochemistry international, 1994, Volume: 25, Issue:1

    Topics: Animals; Apomorphine; Capsules; Dopamine; Immunohistochemistry; Lactic Acid; Male; Microspheres; Neostriatum; Nerve Endings; Nerve Fibers; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Stereotyped Behavior

1994
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
    Drug design, development and therapy, 2012, Volume: 6

    Topics: Animals; Antiparkinson Agents; Benserazide; Blotting, Western; Delayed-Action Preparations; Disease Models, Animal; Down-Regulation; Drug Carriers; Drug Combinations; Dyskinesia, Drug-Induced; Female; Lactic Acid; Levodopa; Microspheres; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, AMPA

2012
Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Scientific reports, 2014, Dec-16, Volume: 4

    Topics: Adrenergic Agents; Animals; Benserazide; Blotting, Western; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Drug Combinations; Dyskinesias; Female; Fluorescent Antibody Technique; Lactic Acid; Levodopa; Microspheres; Neurons; Oxidopamine; Parkinson Disease; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; tau Proteins; Transcription Factors

2014
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
    ACS nano, 2015, May-26, Volume: 9, Issue:5

    Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Dopamine; Dopaminergic Neurons; Drug Carriers; Drug Liberation; Humans; Lactic Acid; Nanoparticles; Neostriatum; Oxidation-Reduction; Oxidopamine; Parkinson Disease; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Receptors, Dopamine; Safety; Up-Regulation

2015
Respiratory deficits in a rat model of Parkinson's disease.
    Neuroscience, 2015, Jun-25, Volume: 297

    Topics: Adrenergic Agents; Animals; Cell Count; Corpus Striatum; Disease Models, Animal; Hydrogen-Ion Concentration; Lactic Acid; Locomotion; Male; Neurons; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pulmonary Ventilation; Rats; Rats, Wistar; Receptors, Neurokinin-1; Respiration Disorders; Respiratory Center; Substantia Nigra; Time Factors

2015
Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
    Journal of molecular neuroscience : MN, 2016, Volume: 59, Issue:2

    Topics: Animals; Astrocytes; Corpus Striatum; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Gliosis; Glutamate Decarboxylase; Glutamic Acid; Glutathione; Lactic Acid; Nerve Tissue Proteins; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide

2016